BridgeBio Pharma Inc (BBIO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $67.61
• Market Cap: $12.75B
• EPS: $-4.21
• 52-Week High: $84.94
• 52-Week Low: $28.32

Market Sentiment

BridgeBio Pharma Inc currently has a Bullish sentiment score of 0.30.

About BridgeBio Pharma Inc

BridgeBio Pharma, Inc. is an innovative biopharmaceutical company headquartered in Palo Alto, California, specializing in the discovery, development, and commercialization of therapies targeting genetic diseases and rare disorders. Leveraging cutting-edge scientific methodologies and a deep understanding of genetic medicine, BridgeBio is committed to addressing significant unmet medical needs, showcasing a diverse pipeline of product candidates with the potential to transform patient care. As...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for BridgeBio Pharma Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BBIO pay dividends?

BridgeBio Pharma Inc (BBIO) does not currently pay a regular dividend.

What is BBIO's market cap?

BridgeBio Pharma Inc (BBIO) has a market capitalization of $12.75B with a current stock price of $67.61.